Results of a Phase I Trial of Induction Cisplatin, Docetaxel, 5-FU and Erlotinib followed by Cisplatin, Bevacizumab and Erlotinib with Radiotherapy for Advanced Head and Neck Cancer

被引：0
|
作者：
Ahn, P. [1 ]
Machtay, M. [2 ]
Anne, P. R. [1 ]
Wuthrick, E. [1 ]
Keane, W. M. [1 ]
Keane, W. M. [1 ]
Cognetti, D. [1 ]
Dicker, A. P. [1 ]
Axelrod, R. S. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Case Western Reserve Univ Hosp, Cleveland, OH 44106 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.1027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S437 / S437
页数：1
相关论文
共 50 条
  • [1] Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer
    Ahn, Peter H.
    Machtay, Mitchell
    Anne, Pramila R.
    Cognetti, David
    Keane, William M.
    Wuthrick, Evan
    Dicker, Adam P.
    Axelrod, Rita S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (05): : 441 - 446
  • [2] Induction chemotherapy with Docetaxel/Cisplatin/5-FU followed by neoadjuvant radiotherapy with simultaneous administration of Docetaxel/Cisplatin followed by OP in locally advanced tumours of the oral cavity - Results of a phase I study
    Grehl, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 89 - 89
  • [3] Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
    Keil, Felix
    Hartl, Maximilian
    Altorjai, Gabriela
    Berghold, Andrea
    Riedl, Regina
    Pecherstorfer, Martin
    Mayrbaeurl, Beate
    De Vries, Alexander
    Schuster, Judith
    Hackl, Jutta
    Fuereder, Thorsten
    Melchardt, Thomas
    Burian, Martin
    Greil, Richard
    EUROPEAN JOURNAL OF CANCER, 2021, 151 : 201 - 210
  • [4] Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer
    Allal, AS
    Zwahlen, D
    Becker, M
    Dulguerov, P
    Mach, N
    CANCER JOURNAL, 2006, 12 (01): : 63 - 68
  • [5] Neoadjuvant Therapy in locally advanced Oral cancer: Chemotherapy induction with Docetaxel/Cisplatin/5-FU followed by concurrent radiation therapy plus Docetaxel/Cisplatin followed by Surgery - Phase I Study: Results and 3J-FU
    Grehl, S.
    Eberhardt, W.
    Poettgen, C.
    Abu Jawad, J.
    Kaelberlah, H. -P
    Gauler, T.
    Arnold, G.
    Mohr, C.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 90 - 90
  • [6] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    Bae, Woo Kyun
    Hwang, Jun Eul
    Shim, Hyun Jeong
    Cho, Sang Hee
    Lee, Joon Kyoo
    Lim, Sang-Chul
    Chung, Woong-Ki
    Chung, Ik-Joo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 589 - 595
  • [7] Phase II study of docetaxel, cisplatin and 5-FU induction chemotherapy followed by concurrent chemoradiotherapy for advanced nasopharyngeal cancer
    Cho, S.
    Bae, W.
    Hwang, J.
    Shim, H.
    Lee, J.
    Lim, S.
    Chung, W.
    Chung, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    Woo Kyun Bae
    Jun Eul Hwang
    Hyun Jeong Shim
    Sang Hee Cho
    Joon Kyoo Lee
    Sang-Chul Lim
    Woong-Ki Chung
    Ik-Joo Chung
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 589 - 595
  • [9] Final results of a phase II study of erlotinib, docetaxel and cisplatin in patients with recurrent/metastatic head and neck cancer
    Kim, E. S.
    Kies, M. S.
    Glisson, B. S.
    Tsao, A.
    Ginsberg, L. E.
    Holsinger, F. C.
    Burke, B. J.
    Truong, M.
    Papadimitrakopoulou, A.
    Lippman, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Phase II trial of docetaxel and cisplatin in 5-FU/cisplatin pretreated refractory esophageal cancer
    Shim, H.
    Bae, W.
    Hwang, J.
    Cho, S.
    Nam, T.
    Chung, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345